Drew Yashar

Drew Yashar is an experienced associate at Capital Factory, focusing on investing to enhance startup connections within Texas's entrepreneurial ecosystem. As an entrepreneurial advisor at the Innovative Genomics Institute, Drew has contributed to building impactful fellowship programs. Additionally, Drew serves as an angel investor for multiple companies, including ENDPOINT HEALTH, Mythic Therapeutics, 64x Bio, and Zafrens, supporting advancements in precision immunology and therapeutic development. Previously, Drew held roles as head editor at BIOS Community, overseeing community engagement for life science professionals, and as a venture systems associate at Alix Ventures. Drew's background in the entrepreneurial ecosystem includes advisory roles and contributions to early-stage investor networks in Boston. Drew holds a Bachelor of Science in Business Administration from Babson College.